molecular biomarker

molecular biomarker

[me¦lek·yə·lər ′bī·ō‚märk·ər]
(medicine)
A biological indicator that signals a changed physiological state, stress, or injury due to disease or the environment, for example, an elevated serum level of prostate-specific antigen is a biomarker for prostate cancer.
References in periodicals archive ?
2) Molecular Biomarker Market - https://www.radiantinsights.com/research/global-molecular-biomarker-market-research-report-2019-2023
In spite of this, all big diagnostic players in the global market are continuously investing in cancer diagnostics including molecular biomarker testing, NGS, PET scanners etc.
These endpoints include specific molecular biomarker changes, as well as pharmacodynamic endpoint analysis of increased new blood vessel growth, blood flow and effect on healing rate.
M2 PHARMA-April 3, 2018-China Issues Patent to Biocept for Target Selector Molecular Biomarker Technology
MiR-195 could be used as potential non-invasive, molecular biomarker for early detection of breast cancer.
Recent molecular biomarker data have shown the importance of microsatellite instability (MSI) testing, a marker of deficient mismatch repair (dMMR), for the selection of patients for immunotherapy (see section on emerging biomarkers below).
The investigators also examined a molecular biomarker of cartilage tissue degradation: the urinary level of C-terminal cross-linking telopeptide of type II collagen, which correlates with radiographic progression of OA.
Altogether, our data indicate that FoxM1 signaling contributes to aggressiveness in a subset of CRC and that the FOXM1 gene may serve as a useful molecular biomarker and potential therapeutic target," the abstract concluded.
The researchers suggest that this mutation could serve as a molecular biomarker to aid doctors in clinical practice, affecting dosing requirements, patients' response to medications and toxicity levels of numerous drugs, especially anti-cancer medications.
WuXi AppTec has entered into a partnership with Qiagen to provide an integrated solution for molecular biomarker development, validation and personalized healthcare targets to their respective clients.
Introgen Therapeutics, Inc.'s use of a molecular biomarker to predict the efficacy of its ADVEXIN cancer therapy was discussed at the American Association for Cancer Research (AACR) international conference.
Using embryos from a genetically-engineered mouse strain, MEGA employs a functional molecular biomarker to improve the detection of toxic media or any other environmental stress that may negatively impact early development.
Full browser ?